Related Experiment Video

Updated: May 9, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Pneumococcal polysaccharide vaccine. Recommendation of the Immunization Practices Advisory Committee

    Annals of Internal Medicine
    |February 1, 1982
    PubMed

    Insights

    Pneumococcal polysaccharide vaccine offers protection against 14 common serotypes, especially for older adults and those with chronic conditions. This vaccine is recommended to reduce infection risk and severity.

    Area of Science:

    • Medicine
    • Immunology
    • Public Health

    Background:

    • Pneumococcal infections pose varying risks across age groups, with increased severity in individuals with chronic diseases.
    • Penicillin is the primary antimicrobial treatment for pneumococcal infections.

    Purpose of the Study:

    • To outline recommendations for a new pneumococcal polysaccharide vaccine.
    • To identify populations most likely to benefit from vaccination.
    • To review vaccine adverse effects and precautions.

    Main Methods:

    • Review of clinical trials demonstrating vaccine efficacy.
    • Analysis of serotype prevalence in the United States.
    • Guidelines for vaccine administration.

    Main Results:

    • The pneumococcal polysaccharide vaccine targets 14 key serotypes responsible for most US infections.
    • Vaccine efficacy has been confirmed through multiple trials.
    • Identification of high-risk groups for vaccination.

    Conclusions:

    • The pneumococcal polysaccharide vaccine is a valuable tool for preventing pneumococcal disease.
    • Vaccination is recommended for specific populations, particularly the elderly and those with chronic illnesses.
    • Understanding potential adverse effects and precautions is crucial for safe administration.

    More Related Videos

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

    Published on: May 19, 2020

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...